Burning Rock Biotech Limited Cash and Cash Equivalents
Burning Rock Biotech Limited (BNR) had Cash and Cash Equivalents of CNY 478.39 million as of 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-04-28
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value 478.39M CNY.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value 519.85M CNY.
- 2023-12-31: Cash and Cash Equivalents, at Carrying Value 615.10M CNY.
- 2022-12-31: Cash and Cash Equivalents, at Carrying Value 905.45M CNY.
CNY
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | 478.39M CNY 20-F · filed 2026-04-28 |
| 2024-12-31 | 519.85M CNY 20-F · filed 2026-04-28 |
| 2023-12-31 | 615.10M CNY 20-F · filed 2026-04-28 |
| 2022-12-31 | 905.45M CNY 20-F · filed 2025-04-29 |
| 2022-06-30 | 1.15B CNY 6-K · filed 2022-11-07 |
| 2021-12-31 | 1.43B CNY 20-F · filed 2024-04-29 |
| 2021-06-30 | 1.85B CNY 6-K · filed 2022-11-07 |
| 2020-12-31 | 1.90B CNY 20-F · filed 2023-04-20 |
| 2019-12-31 | 94.23M CNY 20-F · filed 2022-04-29 |
| 2018-12-31 | 93.34M CNY 20-F · filed 2021-03-23 |
USD
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | $68.41M 20-F · filed 2026-04-28 |
| 2024-12-31 | $71.22M 20-F · filed 2025-04-29 |
| 2023-12-31 | $86.63M 20-F · filed 2024-04-29 |
| 2022-12-31 | $131.28M 20-F · filed 2023-04-20 |
| 2022-06-30 | $171.48M 6-K · filed 2022-11-07 |
| 2021-12-31 | $224.60M 20-F · filed 2022-04-29 |
| 2020-12-31 | $290.47M 20-F · filed 2021-03-23 |